Study of Liver Embolization Techniques for Primary and Secondary Liver Tumors Tracking Outcomes from Short to Long Term

What this Trial Is About

Researchers are studying the outcomes of different embolization techniques used to treat patients with primary and secondary liver tumors. This observational registry aims to assess short, medium, and long-term progression-free survival after embolization, as well as to evaluate residual liver volume in cases where the procedure is used to promote liver regeneration. The study includes patients treated as part of their usual clinical care without additional interventions. The procedure being observed is embolization, an endovascular treatment applied to patients with liver tumors. Participants will continue their normal treatment plans, and the study will not alter their therapeutic approach. The research focuses on tracking clinical outcomes over time following embolization procedures. Participants will be monitored through their regular clinical visits, with researchers collecting data on progression-free survival at intervals from 3 months up to 5 years after the procedure. Residual liver volume will be measured within 40 days post-treatment. Overall survival will also be assessed up to five years. The study involves no extra treatment or interventions beyond standard care, and data collection will follow the patients usual medical schedules.

Liver Embolization Approaches for Tumor Management